Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03973372 · ClinicalTrials.gov registry record
ALTA TIPS: A 5-year Longitudinal Observational Study of Patients Undergoing TIPS Placement
A clinical trial of Cirrhosis, Liver and Transjugular Intrahepatic Portosystemic Shunt (TIPS), sponsored by University of Texas Southwestern Medical Center.
- Active
- Registry status
- 852
- Enrollment target
- 14
- Study locations
NCT03973372: Active study of Cirrhosis, Liver and Transjugular Intrahepatic Portosystemic Shunt (TIPS), sponsored by University of Texas Southwestern Medical Center.
NCT03973372 is a study of Cirrhosis, Liver and Transjugular Intrahepatic Portosystemic Shunt (TIPS) that is active but no longer recruiting, run by University of Texas Southwestern Medical Center. The registered enrollment target is 852 participants, above the 217-participant average among 34 other Cirrhosis, Liver trials with a reported enrollment target (293% higher). The trial reports 14 study locations across 8 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03973372, a study of Cirrhosis, Liver and Transjugular Intrahepatic Portosystemic Shunt (TIPS), is active but no longer recruiting, sponsored by University of Texas Southwestern Medical Center.
- ACTIVE NOT RECRUITING
- Registry status
- 852 participants
- Enrollment target
- 14
- Study locations
Study Summary
ALTA is a multicenter consortium focused on the management of portal hypertension. ALTA TIPS is a longitudinal observational study of patients who are undergoing transjugular intrahepatic portosystemic shunt (TIPS) placement. ALTA will create a database that will provide clinical parameters and outcomes of patients undergoing TIPS as part of their standard of care in hopes of answering key clinical questions.
Primary Outcome
Transjugular Intrahepatic Portosystemic Shunt (TIPS) was first developed as a salvage tool for life threatening variceal bleeding or for the management of severe ascites refractory to medical therapy. Over the past decade there have been improvements in TIPS stent technology resulting in reduction in stent occlusions as well as increased experience of TIPS use. This increase in TIPS use has been paralleled by the expansion of indications for TIPS placement. As TIPS use has increased, so have the
Conditions Studied
Study Locations (14)
California
- Stanford - Redwood City
- Scripps Health - San Diego
- University of California San Francisco - San Francisco
Illinois
- Northwestern - Chicago
- University of Chicago - Chicago
Minnesota
- University of Minnesota - Minneapolis
- Mayo Clinic Rochester - Rochester
New York
- Columbia University - New York
- Weill Cornell - New York
Texas
- Baylor Scott & White Liver Consultants of Texas - Dallas
- University of Texas Southwestern Medical Center - Dallas
Arizona
- University of Arizona - Phoenix
Florida
- University of Florida - Gainesville
Wisconsin
- University of Wisconsin Madison - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 852 participants |
| Start Date | 2019-06-10 |
| Est. Completion | 2027-12 |
What the registry record for NCT03973372 still lists
NCT03973372 is an observational study that tracks outcomes without assigning an intervention. The registered 852 participants enrollment target is mid-sized for trials with a published cap, above the 217-participant average among 34 other Cirrhosis, Liver trials with a reported enrollment target (293% higher).
The record links to 2 conditions, with Cirrhosis, Liver appearing as the primary indexed condition, and to 0 interventions.
NCT03973372 lists 14 locations in 8 states (California, Illinois, Minnesota).
Frequently Asked Questions
What is clinical trial NCT03973372 about?
NCT03973372 is a clinical study titled "ALTA TIPS: A 5-year Longitudinal Observational Study of Patients Undergoing TIPS Placement". ALTA is a multicenter consortium focused on the management of portal hypertension. ALTA TIPS is a longitudinal observational study of patients who are undergoing transjugular intrahepatic portosystemic shunt (TIPS) placement. ALTA will create a database that will provide clinical parameters and outc...
What is the current status of trial NCT03973372?
This trial is currently active not recruiting. The enrollment target is 852 participants. The study started on 2019-06-10. Estimated completion is 2027-12.
What conditions does trial NCT03973372 study?
This clinical trial studies the following conditions: Cirrhosis, Liver, Transjugular Intrahepatic Portosystemic Shunt (TIPS).
Who is sponsoring clinical trial NCT03973372?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03973372 being conducted?
This trial has 14 study locations across Arizona, California, Florida, Illinois, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cirrhosis, Liver
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03973372's enrollment target sits among peer trials
852 3rd of 34 higher than 32 of 34 other Cirrhosis, Liver trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cirrhosis, Liver trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Single and Multiple Dose Escalation of PHIN-214 in Child-Pugh A and B Liver Cirrhotics
RECRUITING · Phase 1
-
Comparison Between 2-dose Versus 3-dose Regimens of Heplisav B in Cirrhosis
RECRUITING · Phase 4
-
Measuring Patient Reported Needs in Outpatient Liver Disease Management
RECRUITING
-
Molecular Mechanism of Exercise in Cirrhosis
RECRUITING · NA
-
Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States
RECRUITING · Phase 2
-
Development of 4D Flow MRI for Risk Stratification of Variceal Bleeding in Cirrhosis
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06237452 · 852 participants · Phase 3
VE303 for Prevention of Recurrent Clostridioides Difficile Infection
- NCT06422143 · 851 participants · Phase 3
Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023]
- NCT07005102 · 854 participants · Phase 2
A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
- NCT07290491 · 854 participants · Phase 3
Spiritual Care or Psychotherapy Versus Palliative Care Alone in Patients With Non-Curative Malignancies
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI